|
|
|
市場調查報告書
全球動物疫苗市場
Veterinary Vaccines
|
本報告已在2012年04月11日停止出版。
更改為出版
Veterinary Vaccines
出版日期 : 2012年02月
商品編碼: 236741
本報告為，調查分析全球動物疫苗市場，匯整寵物疫苗（狗、貓用疫苗）、家畜疫苗（豬、牛、雞、羊、馬及其他動物用疫苗）、等各產品部門，並綜合分析美國、歐洲及其他國家之家畜疫苗市場、2007∼2015年止展望及過去7年表現，以下列摘要形式闡述。
目錄
第1章 簡介、方法論、產品定義
第2章 產業概要及展望
- 不景氣中動物疫苗市場之成長
- 維持穩定成長之家畜疫苗
- 本報告之範圍
第3章 市場趨勢及問題點
- 寵物疫苗
- OTC市場 - 對獸醫之潛在威脅
- 受不景氣影響之小型獸醫
- 牽引市場之寄生蟲驅蟲劑
- 疫苗分類方式
- 禽流感 - 其後續影響
- 疫苗 - 禽流感管理之重要性
第4章 產品概要
- 疫苗
- 動物研究對疫苗生產之貢獻
- 受醫學
- 疫苗開發
- 疫苗生產
- 動物疫苗 - 對動物醫療絕對之必要性
第5章 關於動物疾病
第6章 產品開發及新產品
第7章 近來產品開發及新產品
第8章 近來產業趨勢
第9章 近來企業趨勢
第10章 近來研發
第11章 主要企業
第13章 全球市場展望
第14章 美國
第14章 歐洲
第15章 其他國家
競合企業簡介
Abstract
This report analyzes the worldwide markets for Veterinary Vaccines in US$
Million by the following Product segments - Companion Animal Vaccines (Canine
Vaccines, & Feline Vaccines), and Livestock Vaccines (Porcine Vaccines,
Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines, & Other
Animal Vaccines). The report provides separate comprehensive analytics for the
US, Europe and Rest of World. Annual estimates and forecasts are provided for
each region for the period 2007 through 2015. A seven-year historic analysis
is also provided for these markets. The report profiles 69 companies including
many key and niche players such as Bayer HealthCare AG, Biogenesis-Bago,
Boehringer Ingelheim GmbH, Heska Corporation, Imugene Limited, Indian
Immunologicals Ltd., Lohmann Animal Health, Merck & Co., Inc.,
Intervet/Schering-Plough Animal Health, Merial Ltd., Pfizer, Inc., Embrex,
Inc., Fort Dodge Animal Health, Protein Sciences Corporation, and Virbac
Corporation. Market data and analytics are derived from primary and secondary
research. Company profiles are mostly extracted from URL research and reported
select online sources.
Table of Contents
1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1
- Study Reliability and Reporting Limitations 1
- Disclaimers 2
- Data Interpretation & Reporting Level 3
- Quantitative Techniques & Analytics 3
- Product Definitions and Scope of Study 3
- A. Companion Animal Vaccines 4
- B. Livestock Vaccines 4
- Porcine Vaccines 4
- Bovine Vaccines 4
- Poultry Vaccines 4
- Ovine Vaccines 4
- Equine Vaccines 5
- Other Animal Vaccines 5
2. INDUSTRY OVERVIEW & OUTLOOK 6
- Global Animal Health Care Industry - A Brief Review 6
- Table 1: Global Animal Health Products Market by Region (2008):
Percentage Share Breakdown by Value Sales for North America, Europe, Latin
America and Rest of World (includes corresponding Graph/Chart) 6
- Table 2: Global Animal Health Products Market by Product Group (2008):
Percentage Share Breakdown by Value sales for Parasiticides, Vaccines,
Anti-Infectives, Medical Feed Additives and Other Pharmaceuticals (includes
corresponding Graph/Chart) 6
- Animal Healthcare Market Grows Amidst Recession 7
- Veterinary Vaccines Industry Posts Moderate Growth 7
- Poultry Vaccines Industry: A Global Scenario 7
- Improved Manufacturing Techniques 8
- Improved Analysis 8
- Scope of the Report 8
3. MARKET TRENDS & ISSUES 9
- Companion Animal Vaccines: Trailing on a High Growth Track 9
- OTC Market: A Potential Threat for Veterinarians 9
- Small Animal Practitioners Feel the Pinch of Recession 9
- Parasiticides, Systemic Agents To Drive The Market 9
- Taxonomy of Vaccines 9
- Bird Flu - The Aftermath 10
- Vaccination - Critical for Controlling Avian Influenza Virus 10
4. PRODUCT OVERVIEW 11
- Vaccines - An Evolutionary Scan 11
- Contribution of Animal Research to Vaccine Production 11
- Veterinary Medicines- A Brief Review 12
- Preventive Medicines 12
- Therapeutic Medicines 12
- Others 12
- Development of Vaccines 12
- Production of Vaccines 13
- Veterinary Vaccines - An Essential Component of Animal Health Care 13
- What Does A Veterinary Vaccine Do? 14
- Classification of Veterinary Vaccines 14
- Companion Animals Vaccines 14
- Canine Vaccines 14
- Feline Vaccines 16
- Livestock Vaccines 17
- Bovine Vaccines 17
- Poultry Vaccines 18
- Ovine Vaccines 18
- Porcine Vaccines 19
- Equine Vaccines 19
- Aquaculture Vaccines 19
- A Tabular Analysis on Select Animal Diseases Controlled by Vaccines 20
- Vaccination and Its Reactions 20
- Veterinary Vaccines- Latest Breakthroughs 20
- Marker vaccines 20
- DNA vaccines 20
- Gene-deleted vaccines 21
- Viral-vectored vaccines 21
5. NOTES ON SELECT ANIMAL DISEASES 22
- Brucellosis 22
- Tuberculosis 22
- Johne' s disease 22
- Spirochete Associated Diseases 22
- Respiratory Disease in Goats, Sheep, and Cattle 23
- Porcine Respiratory Diseases 23
- Mastitis 23
- African Swine Fever 23
- Avian Influenza 24
- East Coast Fever 24
- Hemorrhagic Septicemia 24
- Foot-And-Mouth Disease 24
- Japanese Encephalitis 24
- Rift Valley Fever 25
- Equine Virus 25
6. PRODUCT INNOVATIONS/INTRODUCTIONS 26
- Intervet/Schering-Plough Animal Health Introduces a New Web Site for
Innovax recombinant Vaccines Product Line 26
- Pfizer Animal Health Introduces the First E. Coli Bacterial Extract
Vaccine 26
- Intervet Schering-Plough Animal Health Re-Launches EQUILIS(r) StrepE for
Horses 26
- Boehringer Ingelheim Vetmedica Launches Single Shot 3FLEX combination
package PL 26
- Pfizer Animal Health Launches INFORCE(tm) 3 26
- Boehringer Ingelheim Introduces Ingelvac CircoFLEX(r) in Russia 27
- Pfizer Animal Health Introduces Bopriva(r) for Bull and Beef Market in NZ
27
- GALVmed, Inter-African Bureau for Animal Resources Launch ECF Vaccine 27
- BIVI launches Five New Variants of Vetera(r) Vaccines 28
- Hipra Announces Launch of Suiseng(r) 28
- Aceto Corporation Receives Approval to Sell Suppliera[euro](tm) in the US
28
- Intervet Schering-Plough Unleashes NOBIVAC Lyme Vaccine for Dogs 29
- Intervet Schering-Plough Animal Health Introduces PORCILIS PCV Vaccine 29
- Lohmann Launches AviPro(r) MEGAN(r)VAC Vaccination for Salmonella Disease
29
- Intervet Schering Plough Animal Health Introduces Circovirosis Vaccine 29
- Pfizer Animal Health Develops Inovocox(r) Vaccine 29
- Intervet/Schering-Plough Animal Health Launches Bravoxin 10 30
- Bioject and Merial Rolls Out Derma-Vac NF 30
- Defra to Launch Bovine Tuberculosis Vaccine 30
- Intervet International Develops Bluetongue Vaccine 31
- Hester Biosciences Unveils Anti-Coryza Vaccine 31
- Intervet/Schering-Plough Animal Health Introduces Bovilis BTV8 Vaccine 31
- Tecnovax Develops Vaccine for Salmon Virus 31
- Tamil Nadu Veterinary and Animal Science University and The Indian
Veterinary Research Institute Develop Vaccine 31
- Lohmann Animal Health Develops AviPro IBD Xtreme 31
- Intervet/Schering-Plough Animal Health Launches EquiRab(tm) 32
- Lohmann Animal Health Introduces Larger Doses of AviPro(r) ViBursa CE 32
- Lohmann Animal Health International Rolls Out AviBlue 32
- Fort Dodge Animal Health Unveils West Nile-Innovator DNA 33
- Univet Agricultural Products Introduces Coglapest 33
- Intervet/Schering-Plough Animal Health Launches Porcilis(r) COLI 6C 33
- Pfizer Animal Health Unveils FluSure(r) XP Defense System 33
- Pfizer Animal Health Launches Improvac(r) 34
- Intervet/Schering-Plough Animal Health Develops Onset(tm) 5 Intranasal
(IN) Vaccine 34
- Merial Rolls Out BTVPUR AlSap 8 34
- Pfizer Animal Health Introduces FarrowSure(r) GOLD and FarrowSure(r) GOLD
B 35
- Schering-Plough Animal Health Unveils CAVALRY 9 35
- Lohmann Animal Health Develops BTO2 REO Vaccine 35
7. PRODUCT INNOVATIONS/INTRODUCTIONS IN RECENT PAST - A PERSPECTIVE BUILDER 36
- Agroinsuvet Introduces New Vaccines 36
- Merial Rolls Out Vaxxitek(r) HVT+IBD Hatchery Vaccine for Poultry
Industry 36
- Intervet & Friedrich-Loeffler-Institute Develop Dual Vaccine
Prototype for Birds 36
- Schering-Plough Receives USDA License for its Rhusigen(tm) Erysipelas
Vaccine 36
- USDA Approves Use of PreveNile(tm) Vaccine for Horses 37
- Fort Dodge Animal Health Develops Reverse Genetics Avian Vaccine 37
- Boehringer Ingelheim' s Swine Vaccine Gains Approval in Australia 37
- Merial Limited Gets USDA Approval for DNA Vaccine for Melanoma in Dogs 37
- Embrex' s Poultry Vaccine Inovocox Gets USDA Approval 38
- Skystar Bio-Pharmaceutical Develops Avian Influenza Vaccine 38
- United States Department of Agriculture Grants Conditional License for
Necrotic Enteritis Vaccine 38
- Fort Dodge Receives USDA License for Pyramid(r)10 39
- USDA Licenses Use of Fort Dodge' s Suvaxyn(r) PCV2 Vaccine in Pigs 39
- USDA Grants Conditional License to Pfizer' s New Canine Vaccine 39
8. RECENT INDUSTRY ACTIVITY 40
- Centegen Enters into Licensing Partnership with Merial 40
- The Ugandan Government Enters into Partnership with Brentec Vaccines
International 40
- Pfizer Animal Health Kicks Off Equine Business Unit 40
- Pfizer Animal Health Acquires Microtek 40
- GenVec Enters into Collaboration with Merial to Develop and Commercialize
FMD Vaccine 41
- Pfizer Animal Health Inks Global Licensing Deal with Epitopix 41
- Indian Immunologicals Intends to Establish a New Facility in Hyderabad 41
- Pfizer Phases out Animal Vaccine Manufacturing Unit of Wyeth in the
Netherlands 41
- Vivalis Signs Commercial License for EB66(r) Cell Line Platform 42
- Ibio Grants Rights of iBioLaunch platform to Government Funded Project 42
- Intervet/Schering-Plough Animal Health Unveils Production Center at
Boxmeer 42
- Globion India Announced Plans to Develop Eight New Vaccines 42
- Veterinary Services Department Intends to Upgrade VRI 42
- VIVALIS Grants Rights of EB66(r) Cell Line To KYOTO BIKEN 43
- Vical Enters Into Agreement with GenomIdea for Development of DNA Vaccine
43
- Intervet/Schering-Plough Animal Health Unveils the New Freeze-drying and
Specialized Central Filling Unit 43
- Him Electronics Enters into Partnership with Hester Bioscience to Produce
Animal Vaccines 44
- Intervet/Schering-Plough Animal Health Receives Approval for Nobivac
Lepto4 44
- Biolex Enters into Collaboration With Merial for Research and Development
44
- Intervet/Schering-Plough Animal Health Receives Full License from USDA
for Nobivac(r) Vaccine 45
- Intercell Inks License Agreement with Boehringer 45
- Intervet/Schering-Plough Recalls PreveNile West Nile Virus Vaccine in the
US 45
- Merial Gains Full License of ONCEPT(tm) from USDA 45
- Virbac Acquires Veterinary Assets from Pfizer 46
- Harbin Pharmaceutical Group Holding Acquires Animal Vaccine Business From
Pfizer 46
- Boehringer Ingelheim Acquires Certain Cattle Vaccines from Fort Dodge 46
- Virbac Acquires 30% Share in Santa Elena 46
- Merck and Sanofi-Aventis to Merge their Animal Health Business 46
- Elanco to Take Over Pfizer' s Animal Health Products Portfolio 47
- Boehringer Ingelhei to Acquire Pfizer' s Fort Dodge Animal Health Unit 47
- ImmunoVaccine Inks Deal with Pfizer 47
- Merck Merges with Schering-Plough 48
- Pfizer Acquires Wyeth 48
- Merial Receives Marketing License for BTVPUR AlSap 8 Vaccine 48
- Epitopix Obtains Approval to Sell Siderophore Receptor and Porin Vaccine
48
- Phibro Animal Health Acquires Animal Health Division of Abic 49
- Fort Dodge Animal Health and Vivalis Sign Commercial License Deal 49
- Hester Biosciences Expands Gujarat Based Facility 49
- Intervet/Schering-Plough Animal Health Replaces Bovilis(r) IBR Vaccine
with Bovilis(r) IBR Marker Live 50
- Tangshan Yian Biological Engineering Wins Approval from Ministry of
Agriculture of China 50
- Lohmann Animal Health International Signs an Agreement with Celldex
Therapeutics 50
- Intervet/Schering-Plough Animal Health Starts New Manufacturing Facility
50
- Laprovet Commences New Facility 51
- ImmunoVaccine Technologies and La Jolla Institute for Allergy &
Immunology Enter into an Agreement 51
- Merial Signs a Toll Distribution and Manufacturing Agreement with Newport
Laboratories 51
- BOEHRINGER INGELHEIM Animal Health Signs Research License Deal with
Vivalis 52
- AviTech Selects Merial as a Distributor and Service Provider 52
- Bayer Inks Agreement with Juvaris 52
- Pfizer Inks Agreement with ImmunoVaccine Technologies 52
- BioVet Inaugurates BSL-4 Production Unit in India 53
- Vaxine to Take over Protein Sciences 53
- Pfizer Inaugurates a New Development Facility for Veterinary Vaccines 53
- Merial to Establish Animal Vaccine Manufacturing Plant 53
- BNC Bioniche Life Sciences Bags Approval to Sell Econiche Vaccines 53
- Hind Bio-Pharmaceuticals to Establish Animal Vaccines Division 54
- Pfizer' s Animal Health Unit Acquires Schering-Plough' s Product License in
Europe 54
- Grupo Mathiesen Takes Over Centro de Diagnostico Veterinario 54
- Harbin Veterinary Research Institute Opens Animal Vaccine Manufacturing
Base 54
- Bioject Medical Technologies Enters into a Long-Term Supply, Development
and License Contract with Merial 55
- Vivalis SA Signs Letter of Intent with Intervet/ Schering-Plough 55
- Biochemiq Enters into Partnership with Labovet 55
- Microbix Biosystems Purchases Production Plant 55
- Beijing Veterinary Biological Product Factory Starts Operation in New
Plant 55
- Changzhou Tongtai Biopharmaceutical Sets Up Rabies Vaccine Facility 56
- Schering-Plough to Sell Health Products of Animals to Pfizer and Virbac 56
- Pfizer Group Establishes a Veterinary Vaccines Development Center 56
- Phylaxia to Acquire Gazdasagi Radio and Kozep-europai Gazterminal Zrt 56
- Bayer HealthCare AG' s Animal Health Unit Enters into Licensing Agreement
with Juvaris BioTherapeutics 57
- Vivalis Enters into a Commercial License Contract with Virbac 57
- ImmunoVaccine Technologies Signs Licensing Agreement with Pfizer Animal
Health 57
- Kaketsuken and Vivalis Extends Research Collaboration 57
- Heska Amends Distribution Contract with Agri Laboratories 57
- Prevtec Microbia and Saskatchewan Research Council Receives Approval to
Market and Manufacture Coliprotec 58
- Imugene and Merial Enter into an Agreement 58
- Celldex Therapeutics Merges with AVANT Immunotherapeutics' Subsidiary 58
- Ceva Sante Animale Acquires Delvet 58
- Inovio Biomedical Signs Merger Agreement with VGX Pharmaceuticals 59
- Environmental Risk Management Authority Approves equine Influenza Vaccine
59
- Functional Technologies Commences Operations of Phyterra Bio 59
- Summit VetPharm Enters into Distribution Partnership with Webster
Veterinary Unit 59
- PerOs Receives Establishment and Bacterin License from USDA 60
- Wyeth' s Fort Dodge Animal Health Unit Acquires Poultry Vaccines 60
- Boehringer Ingelheim Vetmedica Receives Approval for Express(r) FP and
Express(r) Vaccines from the USDA 60
9. CORPORATE ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER 61
- Merial Bags Major Australian Contract 61
- United States Department of Agriculture Approves Intervet Vaccine 61
- Merial Pockets Ancare 61
- Heska Revises Distribution Agreement with AgriLabs 61
- Animal Health International Acquires Kane Veterinary Supplies 62
- Industrial Equity Investments Pockets Arysta LifeScience 62
- Henry Schein Acquires W&J Dunlop 62
- Tecnovax Establishes New Facility 62
- Pingtung Agricultural to Set Up an Exclusive Veterinary Park 62
- Ouro Fino To Expand Veterinary Product Suite 62
- Alpharma Acquires Yantai Jinhai 62
- Pfizer Animal Health Acquires Embrex 63
- Schering-Plough Acquires Intervet 63
- Schering-Plough Acquires Organon BioSciences 63
- Intervet Sets Up New Animal Vaccine Production Facility in Boxmeer 63
- Crucell Licenses PER.C6(r) Technology to Pfizer Animal Health 64
- Central Veterinary Research Laboratory to Synthesize New Animal Vaccines
64
- Pfizer to Shut Down Omaha Animal Vaccine Center 64
- IGI Licenses Novasomes to Novavax 65
- Bogor Agricultural Institute Collaborates with Shigeta Animal
Pharmaceuticals 65
- Suguna Poultry Steps into Livestock Vaccine Production Business 65
- European Medicines Agency Grants Community Authorization for Nobilis
Influenza H7N1 65
- AVANT Immunotherapeutics & Pfizer Collaborate to Develop Animal
Vaccines 66
- Intervet International Acquires FMD Vaccine Production Facility from
Bayer Healthcare 66
- Canadian Food Inspection Agency Authorizes Bioniche E. Coli O157:H7
Cattle Vaccine for Field Use 66
- Hemispherx Biopharma Acquires DOGS Molecule Patent 67
- Hind Industries to Establish Animal Vaccine Formulations Plant at Patiala
67
- Cryosite and Animal Health Australia Form Partnership 67
- Hester Pharmaceuticals Plans Capacity Expansion 67
- Biovet to Set up Animal Vaccine Plant in Karnataka 67
- Bogor Institute of Agricultureand Shigeta Establish JV for Production of
CLOSE 5.1 Vaccine 67
- IPB Shigeta Acquires Bird Flu Vaccine Rights from MedImmune 68
- Bioject Medical Technologies Signs Three Agreements With Merial 68
- PetCARE Television Network signs Distribution Agreement with Butler
Animal Health Supply 68
- Poultry Vaccine to be produced in Vladimir 68
10. RESEARCH AND DEVELOPMENT IN RECENT PAST 69
- Scientists Develop New Vaccine Against Disease Related to PCV2 69
- Auburn University and Vaxin Researchers Develop Avian Flu Vaccine 69
- UK Researchers Develop In-Shell Vaccine for Chicks 69
- Researchers in Vietnam Decode the H5N1 Virus Gene 70
- Pittsburgh Researchers Create Avian Flu Vaccine from H5N1 Virus 70
- University of Warwick Develops Protecting Virus Method 70
- New Treatment Measure Against Ovine Salmonella & Brucellosis 71
- ICAR Develops Indigenous Bird Flu Vaccine 71
- St. Jude Develops Flu Virus Vaccine through Reverse Genetics 71
- Researchers Develop Vaccine for Swine Disease 71
- Researchers Develop Experimental Vaccine Against 1918 Influenza Virus 72
- Study Proves Effectiveness of Intradermal Vaccine Administration in
Rabbits 72
- CEL-SCI' s CEL-1000 Peptide Shows Adjuvant Activity 73
- Progress in Vaccine for Canine Cancer 73
11. FOCUS ON SELECT GLOBAL PLAYERS 74
- Bayer HealthCare AG (Germany) 74
- Biogenesis-Bago (Argentina) 74
- Boehringer Ingelheim GmbH (Germany) 74
- Heska Corporation (US) 75
- Imugene Limited (Australia) 75
- Indian Immunologicals Ltd (India) 75
- Lohmann Animal Health (US) 76
- Merck & Co., Inc. (US) 76
- Intervet/Schering-Plough Animal Health (The Netherlands) 77
- Merial Ltd. (US) 77
- Pfizer, Inc. (US) 77
- Embrex, Inc. (US) 78
- Fort Dodge Animal Health (US) 78
- Protein Sciences Corporation (US) 79
- Virbac Corporation (US) 79
12. GLOBAL MARKET PERSPECTIVE 80
- Table 3: World Recent Past, Current & Future Analysis for Veterinary
Vaccines by Geographic Region - US, Europe and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007
through 2015 (includes corresponding Graph/Chart) 80
- Table 4: World Historic Review Veterinary Vaccines by Geographic Region -
US, Europe and Rest of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 81
- Table 5: World 11-Year Perspective for Veterinary Vaccines by Geographic
Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World
Markets for Years 2005, 2010 & 2015(includes corresponding Graph/Chart) 82
- Table 6: World Recent Past, Current & Future Analysis for Companion
Animal Vaccines by Geographic Region - US, Europe and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007
through 2015 (includes corresponding Graph/Chart) 83
- Table 7: World Historic Review for Companion Animal Vaccines by Geographic
Region - US, Europe and Rest of World Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart) 84
- Table 8: World 11-Year Perspective for Companion Animal Vaccines by
Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and
Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding
Graph/Chart) 85
- Table 9: World Recent Past, Current & Future Analysis for Companion
Animal Vaccines by Product Segment- Canine Vaccines & Feline Vaccines
Markets Independently Analyzed with Annual Sales Figures in US$ Million for
Years 2007 through 2015 (includes corresponding Graph/Chart) 86
- Table 10: World Historic Review for Companion Animal Vaccines by Product
Segment- Canine Vaccines & Feline Vaccines Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart) 87
- Table 11: World 11-Year Perspective for Companion Animal Vaccines by
Product Segment - Percentage Breakdown of Dollar Sales for Canine Vaccines
& Feline Vaccines Markets for Years 2005, 2010 & 2015 87
- Table 12: World Recent Past, Current & Future Analysis for Canine
Vaccines by Geographic Region - US, Europe and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007
through 2015 (includes corresponding Graph/Chart) 88
- Table 13: World Historic Review for Canine Vaccines by Geographic Region -
US, Europe and Rest of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 89
- Table 14: World 11-Year Perspective for Canine Vaccines by Geographic
region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World
Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 90
- Table 15: World Recent Past, Current & Future Analysis for Feline
Vaccines by Geographic Region - US, Europe and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007
through 2015 (includes corresponding Graph/Chart) 91
- Table 16: World Historic Review for Feline Vaccines by Geographic Region -
US, Europe and Rest of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 92
- Table 17: World 11-Year Perspective for Feline Vaccines by Geographic
Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World
Markets for Years 2005, 2010 & 2015(includes corresponding Graph/Chart) 93
- Table 18: World Recent Past, Current & Future Analysis for Livestock
Vaccines by Geographic Region - US, Europe and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007
through 2015 (includes corresponding Graph/Chart) 94
- Table 19: World Historic Review for Livestock Vaccines by Geographic
Region - US, Europe and Rest of World Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart) 95
- Table 20: World 11-Year Perspective for Livestock Vaccines by Geographic
Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World
Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 96
- Table 21: World Recent Past, Current & Future Analysis for Livestock
Vaccines by Product Segment - Porcine Vaccines, Bovine Vaccines, Poultry
Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines Markets
Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007
through 2015 (includes corresponding Graph/Chart) 97
- Table 22: World Historic Review for Livestock Vaccines by Product Segment
- Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine
Vaccines & Other Animal Vaccines Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart) 98
- Table 23: World 11-Year Perspective for Livestock Vaccines by Product
Segment - Percentage Breakdown of Dollar Sales for Porcine Vaccines, Bovine
Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal
Vaccines Markets for Years 2005, 2010 & 2015 (includes corresponding
Graph/Chart) 99
- Table 24: World Recent Past, Current & Future Analysis for Porcine
Vaccines by Geographic Region - US, Europe and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007
through 2015 (includes corresponding Graph/Chart) 100
- Table 25: World Historic Review for Porcine Vaccines by Geographic Region
- US, Europe and Rest of World Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart) 101
- Table 26: World 11-Year Perspective for Porcine Vaccines by Geographic
Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World
Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
102
- Table 27: World Recent Past, Current and Future Analysis for Bovine
Vaccines by Geographic Region - US, Europe & Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007
through 2015 (includes corresponding Graph/Chart) 103
- Table 28: World Historic Review for Bovine Vaccines by Geographic Region -
US, Europe and Rest of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 104
- Table 29: World 11-Year Perspective for Bovine Vaccines by Geographic
region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World
Markets for Years 2005, 2010 & 2015(includes corresponding Graph/Chart) 105
- Table 30: World Recent Past, Current & Future Analysis for Poultry
Vaccines by Geographic Region - US, Europe and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007
through 2015 (includes corresponding Graph/Chart) 106
- Table 31: World Historic Review for Poultry Vaccines by Geographic Region
- US, Europe and Rest of World Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart) 107
- Table 32: World 11-Year Perspective for Poultry Vaccines by Geographic
region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World
Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
108
- Table 33: World Recent Past, Current & Future Analysis for Ovine
Vaccines by Geographic Region - US, Europe and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007
through 2015 (includes corresponding Graph/Chart) 109
- Table 34: World Historic Review for Ovine Vaccines by Geographic Region -
US, Europe and Rest of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 110
- Table 35: World 11-Year Perspective for Ovine Vaccines by Geographic
region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World
Markets for Years 2005, 2010 & 2015(includes corresponding Graph/Chart) 111
- Table 36: World Recent Past, Current & Future Analysis for Equine
Vaccines by Geographic Region - US, Europe and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007
through 2015 (includes corresponding Graph/Chart) 112
- Table 37: World Historic Review for Equine Vaccines by Geographic Region -
US, Europe and Rest of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 113
- Table 38: World 11-Year Perspective for Equine Vaccines by Geographic
region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World
Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
114
- Table 39: World Recent Past, Current & Future Analysis for Other
Animal Vaccines by Geographic Region - US, Europe and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007
through 2015 (includes corresponding Graph/Chart) 115
- Table 40: World Historic Review for Other Animal Vaccines by Geographic
Region - US, Europe and Rest of World Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart) 116
- Table 41: World 11-Year Perspective for Other Animal Vaccines by
Geographic region - Percentage Breakdown of Dollar Sales for US, Europe and
Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding
Graph/Chart) 117
13. THE UNITED STATES 118
- A. Market Analysis 118
- Current & Future Analysis 118
- H5N1 Virus: A Conundrum for the US Industry 118
- Rabies Cases in the US 118
- B. Market Analytics 119
- Table 42: US Recent Past, Current & Future Analysis for Veterinary
Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine
Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines,
Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other
Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
119
- Table 43: US Historic Review for Veterinary Vaccines by Product
Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline
Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry
Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets
Independently Analyzed with Annual Sales Figures in US$ Million for Years
2000 through 2006 (includes corresponding Graph/Chart) 120
- Table 44: US 11-Year Perspective for Veterinary Vaccines by Product
Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal
Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines
(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine
Vaccines and Other Animal Vaccines) Markets for 2005, 2010 & 2015
(includes corresponding Graph/Chart) 121
14. EUROPE 122
- Market Analysis 122
- Table 45: European Recent Past, Current & Future Analysis for
Veterinary Vaccines by Geographic Region - France, Germany, Italy, United
Kingdom and Rest of Europe Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 122
- Table 46: European Historic Review for Veterinary Vaccines by
Geographic Region - France, Germany, Italy, United Kingdom and Rest of
Europe Markets Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding Graph/Chart) 123
- Table 47: European 11-Year Perspective for Veterinary Vaccines by
Geographic Region - Percentage Breakdown of Dollar Sales for France,
Germany, Italy, United Kingdom and Rest of Europe for Years 2005, 2010 &
2015 (includes corresponding Graph/Chart) 124
- Table 48: European Recent Past, Current & Future for Veterinary
Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine
Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines,
Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other
Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
125
- Table 49: European Historic Review for Veterinary Vaccines by Product
Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline
Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry
Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets
Independently Analyzed with Annual Sales Figures in US$ Million for Years
2000 through 2006 (includes corresponding Graph/Chart) 126
- Table 50: European 11-Year Perspective for Veterinary Vaccines by
Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion
Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines
(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine
Vaccines and Other Animal Vaccines) Markets for Years 2005, 2010 &
2015(includes corresponding Graph/Chart) 127
14a. FRANCE 128
- Market Analysis 128
- Table 51: French Recent Past, Current & Future Analysis for
Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines
(Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine
Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine
Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2015 (includes corresponding Graph/Chart) 128
- Table 52: French Historic Review for Veterinary Vaccines by Product
Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline
Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry
Vaccines, Ovine Vaccines, and Equine Vaccines) Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years 2000 through
2006 (includes corresponding Graph/Chart) 129
- Table 53: French 11-Year Perspective for Veterinary Vaccines by Product
Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal
Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines
(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and
Equine Vaccines) Markets for 2005, 2010 & 2015 (includes corresponding
Graph/Chart) 130
14b. GERMANY 131
- Market Analysis 131
- Table 54: German Recent Past, Current & Future Analysis for
Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines
(Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine
Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine
Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2015 (includes corresponding Graph/Chart) 131
- Table 55: German Historic Review for Veterinary Vaccines by Product
Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline
Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry
Vaccines, Ovine Vaccines and Equine Vaccines) Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000 through 2006
(includes corresponding Graph/Chart) 132
- Table 56: German 11-Year Perspective for Veterinary Vaccines by Product
Group/ Segment - Percentage Breakdown of Dollar Sales for Companion Animal
Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines
(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and
Equine Vaccines) Markets for 2005, 2010 & 2015 (includes corresponding
Graph/Chart) 133
14c. ITALY 134
- Market Analysis 134
- Table 57: Italian Recent Past, Current & Future Analysis for
Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines
(Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine
Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines
and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 134
- Table 58: Italian Historic Review for Veterinary Vaccines by Product
Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline
Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry
Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets
Independently Analyzed with Annual Sales Figures in US$ Million for Years
2000 through 2006 (includes corresponding Graph/Chart) 135
- Table 59: Italian 11-Year Perspective for Veterinary Vaccines by
Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion
Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines
(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine
Vaccines and Other Animal Vaccines) Markets for 2005, 2010 & 2015
(includes corresponding Graph/Chart) 136
14d. THE UNITED KINGDOM 137
- Market Analysis 137
- Table 60: UK Recent Past, Current & Future Analysis for Veterinary
Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine
Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines,
Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other
Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
137
- Table 61: UK Historic Review for Veterinary Vaccines by Product
Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline
Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry
Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets
Independently Analyzed with Annual Sales Figures in US$ Million for Years
2000 through 2006 (includes corresponding Graph/Chart) 138
- Table 62: UK 11-Year Perspective for Veterinary Vaccines by Product
Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal
Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines
(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine
Vaccines and Other Animal Vaccines) Markets for 2005, 2010 & 2015
(includes corresponding Graph/Chart) 139
14e. REST OF EUROPE 140
- A. Market Analysis 140
- Current & Future Analysis 140 A Note on Danish Veterinary Services
140
- The 2002 Standards of Danish Medicines recommend test for antibody
inducing fragments in veterinary vaccines 141
- Hungary Vaccinates Birds Across Zoos 141
- Russia Mass-Produces Vaccines Against Avian Flu 141
- B. Market Analytics 142
- Table 63: Rest of Europe Recent Past, Current & Future Analysis for
Veterinary Vaccines - by Product Group/ Segment for Companion Animal
Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines
(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine
Vaccines and Other Animal Vaccines) Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 142
- Table 64: Rest of Europe Historic Review for Veterinary Vaccines by
Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and
Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,
Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines)
Markets Independently Analyzed with Annual Sales Figures in US$ Million for
Years 2000 through 2006 (includes corresponding Graph/Chart) 143
- Table 65: Rest of Europe 11-Year Perspective for Veterinary Vaccines by
Product/Segment - Percentage Breakdown of Dollar Sales for Companion Animal
Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines
(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine
Vaccines and Other Animal Vaccines) Markets for 2005, 2010 & 2015
(includes corresponding Graph/Chart) 144
15. REST OF WORLD 145
- A. Market Analysis 145
- Current & Future Analysis 145
- Focus on Select Regions 145
- Canada 145
- Overview of Canadian Animal Health Industry 145
- Import and Manufacture of Veterinary Biologics 145
- First to Access E. coli 0157:H7 Vaccine 145
- China 146
- A Glance at the Animal Vaccine Market in China 146
- China Initiates Mass Vaccination Campaign Against Bird Flu Virus 147
- Australia 147
- A Note on Australian Veterinary Therapeutics Market 147
- India 147
- ICAR Develops Indigenous Bird Flu Vaccine 147
- Thailand 147
- Japan & Thailand to Cooperate for Developing Bird Flu Vaccine 147
- Taiwan 148
- Taiwan' s Animal Healthcare Industry Under Scan 148
- Malaysia 148
- Malaysia Initiates Measures to Deal with Potential Flu Pandemic 148
- Kazakhstan 148
- Kazakhstan Takes Proactive Measures Against Bird Flu 148
- North Korea 149
- North Korea Develops Bird Flu Vaccine 149
- Vietnam 149
- Vietnam Imports Bird Flu Vaccines 149
- Egypt 149
- Egypt Reports H5N1 Infection in Vaccinated Flocks 149
- Kenya 149
- Kenya Mass-Manufactures Vaccines Against Rift Valley Fever 149
- B. Market Analytics 150
- Table 66: Rest of World Recent Past, Current & Future Analysis for
Veterinary Vaccines - by Product Group/ Segment for Companion Animal
Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines
(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine
Vaccines and Other Animal Vaccines) Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 150
- Table 67: Rest of World Historic Review for Veterinary Vaccines by
Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and
Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,
Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines)
Markets Independently Analyzed with Annual Sales Figures in US$ Million for
Years 2000 through 2006 (includes corresponding Graph/Chart) 151
- Table 68: Rest of World 11-Year Perspective for Veterinary Vaccines by
Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion
Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines
(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine
Vaccines and Other Animal Vaccines) Markets for 2005, 2010 & 2015
(includes corresponding Graph/Chart) 152
COMPETITIVE LANDSCAPE
|
 |
